Efficacy of IL-2- versus IL-15-stimulated CD8 T cells in adoptive immunotherapy

European Journal of Immunology

Volumn 38, Issue 10, 2008, Pages 2874-2885

  Mueller, Katja ^a   Schweier, Oliver ^a   Pircher, Hanspeter ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cytotoxic T cells; Rodent; Tumor immunity; Viral

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 2;

ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL SURVIVAL; CULTURE MEDIUM; FEMALE; FLOW CYTOMETRY; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; LYMPHOCYTE CULTURE; MALE; MELANOMA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECIPIENT; VIRUS INFECTION; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; EXPERIMENTAL MELANOMA; IMMUNOLOGY; LUNG TUMOR; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; METABOLISM; METASTASIS; TRANSGENIC MOUSE; TUMOR CELL LINE; VIRUS MENINGITIS;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-15; INTERLEUKIN-2; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM METASTASIS;

EID: 58149240223     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838426     Document Type: Article

References (37)

1. Blattman, J. N. and Greenberg, P. D., Cancer immunotherapy: A treatment for the masses. Science 2004. 305: 200-205.
2. June, C. H., Principles of adoptive T cell cancer therapy. J. Clin. Invest. 2007. 117: 1204-1212.
3. Klebanoff, C. A., Gattinoni, L. and Restifo, N. P., CD8+T-cell memory in tumor immunology and immunotherapy. Immunol. Rev. 2006. 211: 214-224.
4. Leen, A. M., Rooney, C. M., and Foster, A. E., Improving T cell therapy for cancer. Annu. Rev. Immunol. 2007. 25: 243-265.
5. Waldmann, T. A., The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 2006. 6: 595-601.
6. Manjunath, N., Shankar, P., Wan, J., Weninger, W., Crowley, M. A., Hieshima, K., Springer, T. A. et al., Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J. Clin. Invest. 2001. 108: 871-878.
7. Cornish, G. H., Sinclair, L. V. and Cantrell, D. A., Differential regulation of T-cell growth by IL-2 and IL-15. Blood 2006. 108: 600-608.
8. Gattinoni, L., Klebanoff, C. A., Palmer, D. C., Wrzesinski, C., Kerstann, K., Yu, Z., Finkelstein, S. E. et al., Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+T cells. J. Clin. Invest. 2005. 115: 1616-1626.
9. Klebanoff, C. A., Finkelstein, S. E., Surman, D. R., Lichtman, M. K., Gattinoni, L., Theoret, M. R., Grewal, N. et al., IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+T cells. Proc. Natl. Acad. Sci. USA 2004. 101: 1969-1974.
10. Klebanoff, C. A., Gattinoni, L., Torabi-Parizi, P., Kerstann, K., Cardones, A. R., Finkelstein, S. E., Palmer, D. C. et al., Central memory self/tumor-reactive CD8+T cells confer superior antitumor immunity compared with effector memory T cells. Proc. Natl. Acad. Sci. USA 2005. 102: 9571-9576.
11. Lotze, M. T., Matory, Y. L., Rayner, A. A., Ettinghausen, S. E., Vetto, J. T., Seipp, C. A. and Rosenberg, S. A., Clinical effects and toxicity of interleukin-2 in patients with cancer. Cancer 1986. 58: 2764-2772.
12. Weninger, W., Crowley, M. A., Manjunath, N. and von Andrian, U. H., Migratory properties of naive, effector, and memory CD8(+) T cells. J. Exp. Med. 2001. 194: 953-966.
13. Carrio, R., Bathe, O. F. and Malek, T. R., Initial antigen encounter programs CD8+T cells competent to develop into memory cells that are activated in an antigen-free, IL-7- and IL-15-rich environment. J. Immunol. 2004. 172: 7315-7323.
14. Kaech, S. M. and Wherry, E. J., Heterogeneity and cell-fate decisions in effector and memory CD8+T cell differentiation during viral infection. Immunity 2007. 27: 393-405.
15. Sallusto, F., Geginat, J. and Lanzavecchia, A., Central memory and effector memory T cell subsets: Function, generation, and maintenance. Annu. Rev. Immunol. 2004. 22: 745-763.
16. Robbins, P. F., Dudley, M. E.,Wunderlich, J., El-Gamil, M., Li, Y. F., Zhou, J., Huang, J. et al., Cutting edge: Persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy. J. Immunol. 2004. 173: 7125-7130.
17. Prevost-Blondel, A., Neuenhahn, M., Rawiel, M. and Pircher, H., Differential requirement of perforin and IFN-gamma in CD8 T cell-mediated immune responses against B16.F10 melanoma cells expressing a viral antigen. Eur. J. Immunol. 2000. 30: 2507-2515.
18. Brentjens, R. J., Latouche, J. B., Santos, E., Marti, F., Gong, M. C., Lyddane, C., King, P. D. et al., Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. Nat. Med. 2003. 9: 279-286.
19. Ku, C. C., Murakami, M., Sakamoto, A., Kappler, J. and Marrack, P., Control of homeostasis of CD8+memory T cells by opposing cytokines. Science 2000. 288: 675-678.
20. Li, X. C., Demirci, G., Ferrari-Lacraz, S., Groves, C., Coyle, A., Malek, T. R. and Strom, T. B., IL-15 and IL-2: A matter of life and death for T cells in vivo. Nat. Med. 2001. 7: 114-118.
21. Stern, J. B., and Smith, K. A., Interleukin-2 induction of T-cell G1 progression and c-myb expression. Science 1986. 233: 203-206.
22. Dubois, S., Mariner, J., Waldmann, T. A. and Tagaya, Y., IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity 2002. 17: 537-547.
23. Giri, J. G., Anderson, D. M., Kumaki, S., Park, L. S., Grabstein, K. H. and Cosman, D., IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J. Leukoc. Biol. 1995. 57: 763-766.
24. Lodolce, J. P., Boone, D. L., Chai, S., Swain, R. E., Dassopoulos, T., Trettin, S. and Ma, A., IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 1998. 9: 669-676.
25. Burkett, P. R., Koka, R., Chien, M., Chai, S., Boone, D. L. and Ma, A., Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+T cell homeostasis. J. Exp. Med. 2004. 200: 825-834.
26. Sato, N., Patel, H. J., Waldmann, T. A., and Tagaya, Y., The IL-15/IL-15Ralpha on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells. Proc. Natl. Acad. Sci. USA 2007. 104: 588-593.
27. Schluns, K. S., Klonowski, K. D. and Lefrancois, L., Transregulation of memory CD8 T-cell proliferation by IL-15Ralpha+bone marrow-derived cells. Blood 2004. 103: 988-994.
28. Tuma, R. A., Giannino, R., Guirnalda, P., Leiner, I., and Pamer, E. G., Rescue of CD8 T cell-mediated antimicrobial immunity with a nonspecific inflammatory stimulus. J. Clin. Invest. 2002. 110: 1493-1501.
29. Lucas, M., Schachterle, W., Oberle, K., Aichele, P. and Diefenbach, A., Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007. 26: 503-517.
30. Byrne, J. A. and Oldstone, M. B., Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection. J. Immunol. 1986. 136: 698-704.
31. Clay, T. M., Custer, M. C., Sachs, J., Hwu, P., Rosenberg, S. A. and Nishimura, M. I., Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. J. Immunol. 1999. 163: 507-513.
32. Kessels, H. W., Wolkers, M. C., van den Boom, M. D., van der Valk, M. A. and Schumacher, T. N., Immunotherapy through TCR gene transfer. Nat. Immunol. 2001. 2: 957-961.
33. Morgan, R. A., Dudley, M. E., Wunderlich, J. R., Hughes, M. S., Yang, J. C., Sherry, R. M., Royal, R. E. et al., Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006. 314: 126-129.
34. Kyburz, D., Aichele, P., Speiser, D. E., Hengartner, H., Zinkernagel, R. M. and Pircher, H., T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur. J. Immunol. 1993. 23: 1956-1962.
35. Prevost-Blondel, A., Zimmermann, C., Stemmer, C., Kulmburg, P., Rosenthal, F. M. and Pircher, H., Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo. J. Immunol. 1998. 161: 2187-2194.
36. Battegay, M., Cooper, S., Althage, A., Banziger, J., Hengartner, H. and Zinkernagel, R. M., Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J. Virol. Methods 1991. 33: 191-198.
37. Rouvier, E., Luciani, M. F. and Golstein, P., Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J. Exp. Med. 1993. 177: 195-200.